Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Macrophages are specialized myeloid cells that play a central role in the innate immune system through the non-specific uptake of extracellular materials, including pathogens, debris, and therapeutic delivery systems (Source: Nature Reviews Immunology). This uptake is primarily mediated by processes such as phagocytosis, macropinocytosis, and endocytosis, which do not always require specific ligand-receptor binding (Source: Journal of Cell Biology). Once internalized, these materials are sequestered within intracellular components, most notably lysosomes, where they undergo enzymatic degradation or storage (Source: Annual Review of Pathology). In the context of pharmacology, this non-specific uptake is a major determinant of the pharmacokinetics and biodistribution of nanomedicines and biologics, often leading to their accumulation in the reticuloendothelial system (RES) (Source: Advanced Drug Delivery Reviews). While this can lead to off-target effects or rapid clearance, it is also exploited for passive targeting in treating intracellular infections or modulating macrophage-driven inflammation (Source: Science Translational Medicine). Consequently, understanding these pathways is vital for optimizing drug delivery and minimizing toxicity in macrophage-rich tissues like the liver and spleen (Source: Nature Nanotechnology). The intracellular components involved, such as the phagosome and lysosome, serve as the ultimate destination for many internalized drugs, influencing their metabolic fate and therapeutic efficacy (Source: Cell). Excessive uptake can lead to macrophage dysfunction or frustrated phagocytosis, which may trigger inflammatory cascades or impair the host's immune response to subsequent challenges (Source: Toxicological Sciences).
Passive accumulation via non-specific endocytic pathways and subsequent sequestration in lysosomal compartments.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Macrophage non-specific cellular uptake and intracellular components (MPS clearance).